Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Enliven Therapeutics Inc shares valued at $122,579 were sold by Patel Anish on May 07 ’25. At $18.39 per share, Patel Anish sold 6,667 shares. The insider’s holdings dropped to 309,976 shares worth approximately $5.52 million following the completion of this transaction.
Also, Patel Anish purchased 6,667 shares, netting a total of over 131,273 in proceeds.
Before that, Lyssikatos Joseph P had sold 5,030 shares from its account. In a trade valued at $100,966, the CHIEF SCIENTIFIC OFFICER traded Enliven Therapeutics Inc shares for $20.07 each. Upon closing the transaction, the insider’s holdings decreased to 5,030 shares, worth approximately $17.69 million.
As published in their initiating research note from BTIG Research on December 13, 2024, Enliven Therapeutics Inc [ELVN] has been a Buy and the price target has been revised to $42. Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in early September. As of June 11, 2024, Robert W. Baird has initiated its “an Outperform” rating for ELVN. Earlier on April 09, 2024, Mizuho initiated its rating. Their recommendation was “a Buy” for ELVN stock.
Analyzing ELVN Stock Performance
During the last five days, there has been a drop of approximately -4.35%. Over the course of the year, Enliven Therapeutics Inc shares have dropped approximately -20.80%. Shares of the company reached a 52-week high of $25.37 on 01/03/25 and a 52-week low of $13.30 on 04/10/25. A 50-day SMA is recorded $19.19, while a 200-day SMA reached $22.71.
Support And Resistance Levels for Enliven Therapeutics Inc (ELVN)
According to the 24-hour chart, there is a support level at 16.06, which, if violated, would cause prices to drop to 14.29. In the upper region, resistance lies at 19.79. The next price resistance is at 21.76. RSI (Relative Strength Index) is 44.48 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.03, which suggests the price will decrease in the coming days. Percent R is at 66.88%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
